Role of somatostatin receptor in pancreatic neuroendocrine tumor development, diagnosis, and therapy

Y Hu, Z Ye, F Wang, Y Qin, X Xu, X Yu… - Frontiers in …, 2021 - frontiersin.org
Pancreatic neuroendocrine tumors (pNETs) are rare and part of the diverse family of
neuroendocrine neoplasms (NENs). Somatostatin receptors (SSTRs), which are widely …

PET with different radiopharmaceuticals in neuroendocrine neoplasms: An umbrella review of published meta-analyses

G Treglia, R Sadeghi, F Giovinazzo, F Galiandro… - Cancers, 2021 - mdpi.com
Simple Summary Functional imaging methods and, in particular, positron emission
tomography (PET) using several radiopharmaceuticals may play a pivotal role in patients …

[68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept

R Laudicella, A Comelli, V Liberini, A Vento, A Stefano… - Cancers, 2022 - mdpi.com
Simple Summary The radiological response assessment of neuroendocrine tumors (NET) to
peptide receptor radionuclide therapy (PRRT) using [177Lu] DOTATOC is still suboptimal …

The challenge of evaluating response to peptide receptor radionuclide therapy in gastroenteropancreatic neuroendocrine tumors: the present and the future

V Liberini, MW Huellner, S Grimaldi, M Finessi… - Diagnostics, 2020 - mdpi.com
The NETTER-1 study has proven peptide receptor radionuclide therapy (PRRT) to be one of
the most effective therapeutic options for metastatic neuroendocrine tumors (NETs) …

Fibroblast activation protein inhibitor (FAPI)-based theranostics—where we are at and where we are heading: a systematic review

MMA Sidrak, MS De Feo, F Corica, J Gorica… - International Journal of …, 2023 - mdpi.com
Cancer is the leading cause of death around the globe, followed by heart disease and
stroke, with the highest mortality to this day. We have reached great levels of understanding …

Personalized dosimetry in the context of radioiodine therapy for differentiated thyroid cancer

M Pacilio, M Conte, V Frantellizzi, MS De Feo… - Diagnostics, 2022 - mdpi.com
The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more
than 95% of cases. A suitable choice for the treatment of DTC is the systemic administration …

Radiolabeled somatostatin analogues for diagnosis and treatment of neuroendocrine tumors

V Ambrosini, L Zanoni, A Filice, G Lamberti, G Argalia… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors,
presenting in often challenging clinical scenarios, and require multidisciplinary discussion …

Role of PET/CT and therapy management of pancreatic neuroendocrine tumors

D Calabrò, G Argalia, V Ambrosini - Diagnostics, 2020 - mdpi.com
Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show peculiar clinical and histomorphological features …

Diagnostic management of gastroenteropancreatic neuroendocrine neoplasms: technique optimization and tips and tricks for radiologists

F Pellegrino, V Granata, R Fusco, F Grassi, S Tafuto… - Tomography, 2023 - mdpi.com
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) comprise a
heterogeneous group of neoplasms, which derive from cells of the diffuse neuroendocrine …

Dual tracer 68Ga-DOTATOC and 18F-FDG PET improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms

P Mapelli, S Partelli, M Salgarello, J Doraku, F Muffatti… - Diagnostics, 2021 - mdpi.com
Purpose: To define an imaging risk profile in a population of patients affected by Pancreatic
neuroendocrine neoplasms (PanNENs) candidates to surgery, by assessing the predictive …